Last edition
News about Global Pharma
Moleculin Announces Additional Annamycin Patent Allowances
Moleculin Biotech, Inc., a late-stage pharmaceutical company focused on developing innovative treatments for hard-to-treat cancers and viruses, has received a Notice of Intent to Grant for its European patent application covering the formulation of liposomal Annamycin.
Global Pharma | 07/03/2025 | By Manvi | 208
Zydus Secures Final Approval from USFDA for Dasatinib Tablets in Multiple Doses
Zydus Lifesciences has received USFDA approval to manufacture Dasatinib tablets 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg for treating Philadelphia chromosome-positive leukaemias. These tablets will be produced in the company’s Ahmedabad facility.
Global Pharma | 07/03/2025 | By Manvi | 477
Enzene Bags EU GMP Certification for its Facilities in India
Enzene is a fully integrated, end-to-end CDMO with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA).
Global Pharma | 07/03/2025 | By Aishwarya | 518
Astellas and YASKAWA to Establish Joint Venture Focused on Cell Therapy Manufacturing
The planned joint venture will leverage Astellas' expertise in R&D and manufacturing for cell therapy and the dual arm robot ‘Maholo’, developed by YASKAWA's subsidiary, Robotic Biology Institute.
Global Pharma | 06/03/2025 | By Aishwarya | 336
Syntegon to Showcase New Filling Solution for RTU Syringes at Interphex
A new robotic handling unit is also at the heart of Syntegon’s patented Settle Plate Changer. It automates viable monitoring during sterile product filling.
Global Pharma | 06/03/2025 | By Aishwarya | 608
Scinai Immunotherapeutics Ltd. announced that it has entered into a Standby Equity Purchase Agreement (the SEPA) with YA II PN, Ltd. (Yorkville), a fund managed by Yorkville Advisors Global, LP.
Global Pharma | 05/03/2025 | By Manvi | 265
Senores Pharmaceuticals Strengthens Global Presence with New USFDA Approvals
The acquisition includes 13 ANDAs that have already received approval from the US Food and Drug Administration (USFDA) and one ANDA that is currently pending approval.
Global Pharma | 05/03/2025 | By Aishwarya | 714
Bhimrao Jadhav Joins NATCO Pharma as Senior VP of Formulations Operations
Jadhav holds a Bachelor’s degree in Pharmacy and brings over 30 years of experience in pharmaceutical operations management.
Global Pharma | 05/03/2025 | By Aishwarya | 1181
Frontier Scientific Solutions Announces Appointment of Keith Parent as CTO
Frontier Scientific Solutions, a provider of GMP temperature-controlled storage and Free Trade Zone (FTZ) services for the life sciences industry, announced the appointment of Keith Parent as Chief Technology Officer (CTO).
Global Pharma | 04/03/2025 | By Manvi | 456
Zydus to Develop Combination Vaccine for Shigellosis and Typhoid
Zydus Lifesciences Ltd. has announced the development of the world’s first combination vaccine for shigellosis and typhoid, supported by the Gates Foundation, to address critical gaps in childhood immunization.
Global Pharma | 04/03/2025 | By Manvi | 166
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy